ArticleCardiovascular and interventional radiology2025
Prognostication of Three-Month Genicular Artery Embolization Outcomes Using Pre-Procedural MRIs.
Article in Cardiovascular and interventional radiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Outcome and Safety of Genicular Artery Embolization for Knee Osteoarthritis: A Systematic Review and Meta-Analysis.Cardiovascular and interventional radiology · 2026Pooled it
- Retrospective Comparison of Short- and Mid-Term Performance of 200-µm Polyethylene Glycol Microspheres vs Ethiodized Oil Emulsion for Genicular Artery Embolization in Symptomatic Knee Osteoarthritis.Cardiovascular and interventional radiology · 2026Article
- Multimodality imaging considerations for genicular artery embolization in knee osteoarthritis.World journal of radiology · 2026Review
- Genicular Artery Embolization Using Resorbable Gelatin Microspheres for Refractory Knee Pain: Technique, Safety and Clinical Outcome.Cardiovascular and interventional radiology · 2026Observational
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeTo assess the utility of pre-procedural knee MRI prior to genicular artery embolization (GAE) for the prognostication of early outcomes for symptomatic knee osteoarthritis (KOA). MATERIALS AND
methodsA single-center study including 39 patients received GAE from 9/2021-4/2025 with pre-procedural MRIs. MRIs were evaluated for structural abnormalities including menisci, ligaments, cartilage, marrow signal, and loose bodies. For 24 patients, synovitis was assessed using a semiquantitative method. Clinical outcomes were measured with the Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) scoring system at pre-GAE and three-month postintervention. Categorical response was assessed as a 50% reduction in the WOMAC Pain. Student t-tests were used to evaluate WOMAC pain reduction, and subset analysis was performed between MRI structural abnormalities and categorical response.
resultsFifty-two knees received GAE with pre-procedural MRIs (33 with contrast). There was a 34.6% clinical response rate (N = 8/52). Lateral meniscus and cartilage abnormality were predictive of poor categorical response at three months (P = 0.039-0.040). ≥ 4 structural abnormalities were associated with poor treatment response (P = 0.004). Pre-GAE synovitis was not predictive of categorical response at three months (P = 0.809). Kellgren-Lawrence ≥ 3 was predictive of poor response (P < 0.001). Lower adverse event rate was observed with temporary embolic compared to permanent embolic (P = 0.032).
conclusionPre-GAE knee MRI may offer short-term prognostic utility. Pre-procedural abnormalities in the lateral menisci and cartilage can predict poor response to GAE at three months. A greater degree of structural abnormality (≥ 4 structural abnormalities) was associated with poor response. Temporary embolic agent may be safer than permanent embolic agent.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.